BREAKING LIVE All breaking →
News

XTB shares plunge as much as 19% as Polish regulator revives CFD restriction threat

XTB fell by as much as 19% on 17 November after a senior KNF official again signalled a product intervention on CFDs, the broker's main product. The scale of any measure is unclear.

ED
by Enrico Danieletto with UCapital AIUCapital News newsroom5 min read
XTB shares plunge as much as 19% as Polish regulator revives CFD restriction threat
AI-generated image
KEY POINTS
  1. 01XTB (XTB.WAR) fell as much as 19% on 17 November after the KNF signalled possible limits on retail CFD access.
  2. 02CFDs made up nearly 93% of XTB's trading revenue in the first nine months of 2026.
  3. 03KNF deputy chairman Dariusz Adamski said the regulator has several product intervention ideas it will present shortly.
  4. 04XTB's year-to-date gain has been trimmed to 61%; its next results are due on 20 November.

Shares in Polish retail trading platform XTB (XTB.WAR) fell by as much as 19% on 17 November after the Polish Financial Supervision Authority (KNF) again signalled that retail investors' access to contracts for difference may be restricted. The move revived concerns about the sustainability of the company's business model.

For investors, the issue is the weight of the product in question: CFDs are XTB's core offering, so any CFD regulation in Poland goes straight to the broker's earnings. What the KNF will actually propose remains unknown, which is why analysts struggle to size the impact.

What happened

XTB shares dropped sharply on 17 November after Dariusz Adamski, deputy chairman of the KNF, spoke at the Parkiet investment conference. He said the regulator has several ideas for a product intervention and will present them shortly.

Adamski described CFDs as a form of speculation, not investment. He added that, while CFDs are proper instruments for hedging, they carry risk not only for inexperienced investors but also for experienced ones. The KNF had not immediately responded to an email seeking comment.

The comments echo remarks Adamski made in May, when XTB also fell as the Polish regulator signalled tighter access to CFDs. This time the regulator has been more vocal, according to one analyst quoted below.

  • Intraday fall: as much as 19% on 17 November.
  • CFD share of trading revenue: nearly 93% in the first nine months of 2026.
  • Year-to-date gain: trimmed to 61%.
  • Next results: 20 November 2026.

What are CFDs and why do they matter to XTB?

CFDs, or contracts for difference, allow investors to trade with leverage without owning the underlying assets. They are the most popular instruments on XTB's platform, accounting for nearly 93% of all trading revenue in the first nine months of 2026.

That concentration explains the size of the reaction. A restriction on retail access to the product would hit the bulk of the broker's revenue rather than a side line.

The KNF already publishes on its website a section on product interventions, which lists an earlier intervention setting restrictions on the marketing, distribution and sale of CFDs to retail clients, as well as a ban on binary options for retail clients. Product intervention is therefore an established tool in the regulator's toolkit, though the new measures have not been detailed.

How did analysts react?

Analysts said the reaction was understandable but that the impact is hard to measure. Lukasz Janczak of Erste (neutral) said the scale of the fall may be understandable, given that CFDs are the main product used by XTB clients.

Janczak also noted that the regulator's comments come when XTB's valuation appears demanding after an earlier rally, weaker third-quarter earnings and a more challenging outlook for fourth-quarter results. He said the effect of the regulatory risk is difficult to quantify because it is unclear what measures the regulator may ultimately introduce.

Mateusz Chrzanowski of Noble Securities said plans for new regulation of CFD instruments, combined with the hawkish stance of the KNF deputy chair, may lead investors to price in a negative scenario involving significant restrictions. He said this is likely to weigh on the share price in the near term.

Mikolaj Lemanczyk of mBank said the regulator's comments lack details, making any specific scenario hard to assess. He pointed to a decision by the Spanish regulator a few years ago that banned all marketing if CFDs were part of the offering, which he called a potentially extremely negative outcome.

It is important to make investors aware that CFDs are a form of speculation, not investment.

Dariusz Adamski, deputy chairman of the KNF, at the Parkiet investment conference on 17 November.

What is XTB's financial position?

XTB's latest reported quarter showed earnings per share of 4.19 against an estimate of 4.15, and revenue of 0.99 billion in the reporting currency against an estimate of 0.91 billion. The trailing price-to-earnings ratio stands at 11.55, according to market data.

Erste's Janczak nonetheless described third-quarter earnings as weaker and the outlook for the fourth quarter as more challenging. XTB's rally halted in September after company founder Jakub Zablocki sold an 8% stake. The shares have since trimmed their year-to-date gain to 61%.

Why it matters

The episode matters because XTB's earnings depend almost entirely on a product that its home regulator is openly questioning. With nearly 93% of trading revenue coming from CFDs in the first nine months of 2026, the outcome of the KNF's review bears directly on the company's profit.

Regulatory uncertainty has been a recurring theme. Lemanczyk said the market is to some extent trading the same theme as before, with the KNF now more vocal. He added that the term "product intervention" is very broad, which makes it hard to quantify the potential effect on earnings.

What are the risks and counterpoints?

The main uncertainty is scope. Measures could range from limits on leverage or marketing to wider restrictions on retail access, and none has been specified. Adamski's acknowledgement that CFDs are proper hedging instruments suggests the regulator's focus is on retail speculation, but the sources do not say what form the intervention will take.

Valuation adds another layer. Erste said the shares looked demanding after the earlier rally, so the sell-off combines regulatory fear with concerns over earnings momentum.

What to watch next

The next catalysts are the KNF's promised product intervention proposals and XTB's results. Adamski said the regulator would present its ideas shortly, without giving a date.

  • KNF publication of its product intervention proposals on CFDs: date not given.
  • XTB's next report: 20 November 2026.
  • Any response from the KNF to requests for comment on the 17 November remarks.
  • Analyst assessments of the fourth-quarter outlook flagged by Erste.

Sources:UCapital Markets (ucapital.com)knf.gov.pl

polish financial supervision authority (knf)dariusz adamskijakub zablockicfd regulation
DISCLOSURE

UCapital24 S.p.A. or group companies may have commercial relationships with the companies mentioned. This content is not financial advice.

✦ Ask the AI about this article

Sign up for free to ask the AI about this article.

Analyse the markets with UCapital’s AI agents

Multiples, financials, sentiment and risks in 60 seconds, with live data.

Open Markets →

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.